126 related articles for article (PubMed ID: 15929104)
1. Variant lymphoproliferative disorder of granular lymphocytes (LDGL) following Hodgkin lymphoma.
Jenkins BD; Snower D; Mohamed A; Al-Katib A
Am J Hematol; 2005 Jun; 79(2):128-31. PubMed ID: 15929104
[TBL] [Abstract][Full Text] [Related]
2. Pohl-Pinkus constrictions of hair following chemotherapy for Hodgkin's disease.
Williamson PJ; de Berker D
Br J Haematol; 2005 Mar; 128(5):582. PubMed ID: 15725077
[No Abstract] [Full Text] [Related]
3. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A;
J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521
[TBL] [Abstract][Full Text] [Related]
4. HIV-associated Hodgkin lymphoma.
Carbone A; Gloghini A; Serraino D; Spina M
Curr Opin HIV AIDS; 2009 Jan; 4(1):3-10. PubMed ID: 19339934
[TBL] [Abstract][Full Text] [Related]
5. The number of tumor infiltrating T-cell subsets in lymph nodes from patients with Hodgkin lymphoma is associated with the outcome after first line ABVD therapy.
Alonso-Álvarez S; Vidriales MB; Caballero MD; Blanco O; Puig N; Martin A; Peñarrubia MJ; Zato E; Galende J; Bárez A; Alcoceba M; Orfão A; González M; García-Sanz R
Leuk Lymphoma; 2017 May; 58(5):1144-1152. PubMed ID: 27733075
[TBL] [Abstract][Full Text] [Related]
6. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
Brusamolino E; Baio A; Orlandi E; Arcaini L; Passamonti F; Griva V; Casagrande W; Pascutto C; Franchini P; Lazzarino M
Clin Cancer Res; 2006 Nov; 12(21):6487-93. PubMed ID: 17085663
[TBL] [Abstract][Full Text] [Related]
7. Early versus late intensification for patients with high-risk Hodgkin lymphoma-3 cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation: five-year results of a randomized trial on behalf of the GOELAMS Group.
Arakelyan N; Berthou C; Desablens B; de Guibert S; Delwail V; Moles MP; Quittet P; Jais JP; Colonna P; Andrieu JM;
Cancer; 2008 Dec; 113(12):3323-30. PubMed ID: 18988286
[TBL] [Abstract][Full Text] [Related]
8. Genomic chaos in peripheral blood lymphocytes of Hodgkin's lymphoma patients one year after ABVD chemotherapy/radiotherapy.
Ramos S; Navarrete-Meneses P; Molina B; Cervantes-Barragán DE; Lozano V; Gallardo E; Marchetti F; Frias S
Environ Mol Mutagen; 2018 Oct; 59(8):755-768. PubMed ID: 30260497
[TBL] [Abstract][Full Text] [Related]
9. How important is bleomycin in the adriamycin + bleomycin + vinblastine + dacarbazine regimen?
Canellos GP; Duggan D; Johnson J; Niedzwiecki D
J Clin Oncol; 2004 Apr; 22(8):1532-3. PubMed ID: 15084636
[No Abstract] [Full Text] [Related]
10. ABVD plus rituximab
Strati P; Fanale MA; Oki Y; Turturro F; Fayad LE; Bartlett NL; Gladstone DE; Kasamon YL; Portlock CS; Wilson WH; Goy A; Younes A; Lee HJ
Haematologica; 2019 Feb; 104(2):e65-e67. PubMed ID: 30190343
[No Abstract] [Full Text] [Related]
11. [Clinical analysis of reactive thymic hyperplasia following chemotherapy for childhood malignant lymphoma].
Zhen ZJ; Sun XF; Xia Y; Wang ZH; Ling JY
Ai Zheng; 2006 Apr; 25(4):471-5. PubMed ID: 16613683
[TBL] [Abstract][Full Text] [Related]
12. Vanishing bile duct syndrome occurring after high-dose chemotherapy and autologous peripheral stem cell transplantation in a patient with Hodgkin's disease.
Kömürcü S; Ozet A; Altundag MK; Arpaci F; Oztürk B; Celasun B; Tezcan Y
Ann Hematol; 2002 Jan; 81(1):57-8. PubMed ID: 11807639
[No Abstract] [Full Text] [Related]
13. Bilateral sudden hearing loss following ABVD protocol.
Tazi I; Nafil H; Mahmal L
J Cancer Res Ther; 2014; 10(1):212. PubMed ID: 24762521
[No Abstract] [Full Text] [Related]
14. [Hodgkin's disease in pregnancy--case report and literature review].
Schäffer M; Hegenbart U; Klostermann K; Stepan H
Z Geburtshilfe Neonatol; 2003; 207(2):71-3. PubMed ID: 12740750
[TBL] [Abstract][Full Text] [Related]
15. Will BEACOPP be the standard for high risk Hodgkin lymphoma patients in advanced stages?
Diehl V; Fuchs M;
Transfus Apher Sci; 2007 Aug; 37(1):37-41. PubMed ID: 17714996
[TBL] [Abstract][Full Text] [Related]
16. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of interim positron emission tomography (PET)-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL): a sub-analysis of SWOG S0816 Phase 2 trial.
Danilov AV; Li H; Press OW; Shapira I; Swinnen LJ; Noy A; Reid E; Smith SM; Friedberg JW
Leuk Lymphoma; 2017 Feb; 58(2):461-465. PubMed ID: 27386786
[No Abstract] [Full Text] [Related]
18. Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial.
Engert A; Franklin J; Eich HT; Brillant C; Sehlen S; Cartoni C; Herrmann R; Pfreundschuh M; Sieber M; Tesch H; Franke A; Koch P; de Wit M; Paulus U; Hasenclever D; Loeffler M; Müller RP; Müller-Hermelink HK; Dühmke E; Diehl V
J Clin Oncol; 2007 Aug; 25(23):3495-502. PubMed ID: 17606976
[TBL] [Abstract][Full Text] [Related]
19. Current role and future developments of radiotherapy in early-stage favourable Hodgkin's lymphoma.
Eich HT; Müller RP
Strahlenther Onkol; 2007 Dec; 183 Spec No 2():16-8. PubMed ID: 18167000
[No Abstract] [Full Text] [Related]
20. Molecular and flow cytometry characterization during the follow-up of three simultaneous lymphoproliferative disorders: hairy cell leukemia, monoclonal B-cell lymphocytosis, and CD4(++) /CD8(+/- dim) T-large granular lymphocytosis--a case report.
Garrido P; Jiménez P; Sánchez C; Valero F; Balanzategui A; Almagro M; López P; de Pablos JM; Navarro P; Cabrera A; González M; Jurado M; Ruiz-Cabello F
Cytometry B Clin Cytom; 2011 May; 80(3):195-200. PubMed ID: 21520406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
